跳至主要内容
临床试验/NCT02484898
NCT02484898已完成不适用

SEEQ™ Performance Study

Medtronic Cardiac Rhythm and Heart Failure0 个研究点目标入组 200 人开始时间: 2015年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200
主要终点
Diagnostic Yield of the SEEQ™ MCT/ECM System

研究概览

简要总结

The purpose of the Medtronic SEEQ™ Performance study is to build further evidence on the clinical and economic benefit of the Medtronic market-released SEEQ™ Mobile Cardiac Telemetry System/External Cardiac Monitor System (MCT/ECM).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is indicated for a SEEQ™ MCT/ECM System for approved indications
  • Patient is 18 years of age or older
  • Patient is willing and able to provide consent and authorize the use and disclosure of health information
  • Patient is willing and able to comply with the protocol

排除标准

  • Patient has known allergy and/or hypersensitivity to adhesives or hydrogel.
  • Patient has suspected potential life-threatening arrhythmias, or requires in-subject/in-hospital monitoring.
  • Patient will undergo a medical procedure that would preclude full participate during the prescribed duration of the SEEQ™
  • Patient has an implanted cardiac device, (e.g., pacemaker, Implantable Cardioverter Defibrillator, Cardiac Resynchronization Therapy)

结局指标

主要结局

Diagnostic Yield of the SEEQ™ MCT/ECM System

时间窗: 120 Days

次要结局

未报告次要终点

研究者

发起方
Medtronic Cardiac Rhythm and Heart Failure
申办方类型
Industry
责任方
Sponsor

相似试验